ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Kobayashi Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -0.55% and Operating profit at -2.92% over the last 5 years
2
Flat results in Jun 25
- INTEREST(Q) At JPY 8 MM has Grown at 100%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.6%
3
With ROE of 8.92%, it has a expensive valuation with a 2.05 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -13.52%, its profits have fallen by -8.8%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -13.52% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Kobayashi Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kobayashi Pharmaceutical Co., Ltd.
-13.52%
-0.35
19.72%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.55%
EBIT Growth (5y)
-2.92%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.81
Tax Ratio
23.82%
Dividend Payout Ratio
75.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.70%
ROE (avg)
10.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.05
EV to EBIT
15.97
EV to EBITDA
11.60
EV to Capital Employed
2.55
EV to Sales
2.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.96%
ROE (Latest)
8.92%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 1% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.75%
DIVIDEND PER SHARE(HY)
Highest at JPY 4.75
-3What is not working for the Company
INTEREST(Q)
At JPY 8 MM has Grown at 100%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.6%
Here's what is working for Kobayashi Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Highest at 4.75%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend per share
Highest at JPY 4.75
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Raw Material Cost
Fallen by 1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Kobayashi Pharmaceutical Co., Ltd.
Interest
At JPY 8 MM has Grown at 100%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 2.6%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
